Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nirvana Life Sciences Inc. (NIRV.CN)

Nirvana Life Sciences Inc. (NIRV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nirvana Life Sciences Inc. 650 West Georgia Street Suite 2110 Vancouver BC V6B 4N8 CAN

P: 604-689-1280

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Key Statistics

Overview:

Market Capitalization, $K 115
Shares Outstanding, K 22,923

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -366 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -91 K

Growth:

1-Year Return -98.57%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 12/29/25
Next Earnings Date N/A
Earnings Per Share ttm 0.01
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -110.11%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 03/24/25

NIRV.CN Ratios

Ratio
Price/Earnings ttm 0.50
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -1,872.78%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -0.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar